Key result
Visceral Adiposity Index was the sole determinant of adiponectin levels and, along with age, predicted the presence of impaired fasting glucose or diabetes.
Why the study?
Is the Visceral Adiposity Index associated with adiponectin levels and glycaemic disturbances in adult subjects?
Cohort (n=308)
Is the Visceral Adiposity Index associated with adiponectin levels and glycaemic disturbances in adult subjects?
The Visceral Adiposity Index is a simple clinical tool that correlates with adiponectin levels and the risk of impaired glucose metabolism.
Answers are grounded in this paper and cite their sources.
VAI associates with adiponectin and glycaemic risk in cohort data; hypothesis-generating and requires prospective validation before clinical use.
BACKGROUND: Visceral Adiposity Index (VAI) is a gender-specific mathematical index estimated with the use of simple anthropometric (body mass index and waist circumference) and biochemical (triglycerides and high density lipoprotein cholesterol) parameters. Recent studies have shown that VAI reflects accurately the degree of visceral adiposity and insulin resistance. However, up to now, VAI has not been evaluated if it correlates with carbohydrate metabolism disorders, as well as with adipokine secretion from the fat mass. METHODS: In a cohort of 308 out of 414 adult Saudi subjects screened for the study, detailed personal medical history, anthropometrics and metabolic/hormonal profiles were obtained. Additionally, the circulating concentrations of several circulating adipokines, namely adiponectin, leptin, tumour necrosis factor-α (TNF-α) and resistin, were measured. RESULTS: Stepwise multivariate analysis showed that VAI was the sole determinant of adiponectin levels (R(2) = 0·07, beta ± SE: -0·25 ± 0·05), while BMI and female gender predicted leptin levels (R(2) = 0·26, 0·10 ± 0·01 and 0·61 ± 0·15, respectively). Furthermore, the presence of impaired fasting glucose (IFG)/diabetes was predicted only by age and VAI. CONCLUSIONS: We report for the first time the direct relations of VAI with adipose tissue secretion, as well as with functional glycaemic disorders. Because VAI is estimated easily with data obtained in everyday practice, it could be used as an indirect index of adiponectin levels and the risk of impaired glucose metabolism.
No takes yet. Share an insight, caveat, or question.
Al‐Daghri et al. (2012) reported a cohort. Visceral Adiposity Index (VAI) was evaluated on Adiponectin levels (beta -0.25). Visceral Adiposity Index was the sole determinant of adiponectin levels and, along with age, predicted the presence of impaired fasting glucose or diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: